Related Experiment Video
Updated: Jun 3, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
An update on the islet renin-angiotensin system.
1Faculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Peptides
|March 15, 2011
Summary
The local pancreatic renin-angiotensin system (RAS) regulates islet function and glycemic control. Novel findings suggest it interacts with glucagon-like peptide-1 (GLP-1) and vitamin D to protect beta cells in diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- The renin-angiotensin system (RAS) is crucial in regulating blood pressure and fluid balance.
- Novel RAS components and pathways are continuously being discovered, increasing the system's complexity.
- The local pancreatic RAS, identified in islets, influences islet cell mass, inflammation, and ion channels, impacting glycemic control.
Purpose of the Study:
- To review the local islet RAS.
- To highlight recent findings on islet RAS.
- To discuss its role in islet function and glycemic control.
Main Methods:
- Literature review of existing studies on pancreatic RAS.
- Analysis of recent research on islet RAS components and signaling pathways.
- Exploration of interactions between islet RAS, GLP-1, and vitamin D.
Main Results:
- The local pancreatic RAS plays a significant role in regulating islet function and glycemic control.
- Factors like GLP-1 and vitamin D may interact with islet RAS signaling.
- This interaction could protect pancreatic beta cells under diabetic and hyperglycemic conditions.
Conclusions:
- The local islet RAS is a key regulator of pancreatic islet function and glucose homeostasis.
- Understanding these complex interactions is vital for developing new therapeutic strategies for metabolic diseases.
- Further research into the interplay of islet RAS, GLP-1, and vitamin D is warranted.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:29Renal Regulation of Acid-Base Balance
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...